Aerovate Therapeutics, Inc. Uncategorized Contracts & Agreements

11 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 1 to Antibody Discovery and Option Agreement, dated as of September 27, 2024
Aerovate Therapeutics, Inc.
Biotechnology
2024
Offer Letter between Jade Biosciences, Inc. and Hetal Kocinsky, dated as of September 3, 2024
Aerovate Therapeutics, Inc.
Biotechnology
CT
2024
Antibody Discovery and Option agreement, dated July 24, 2024, by and between Paragon Therapeutics, Inc., Parade Biosciences Holding, LLC and Jade Biosciences, Inc
Aerovate Therapeutics, Inc.
Biotechnology
MA
2024
Offer Letter between Jade Biosciences, Inc. and Elizabeth Balta, dated as of October 21, 2024
Aerovate Therapeutics, Inc.
Biotechnology
WA
2024
Offer Letter between Jade Biosciences, Inc. and Andrew King, dated as of July 31, 2024
Aerovate Therapeutics, Inc.
Biotechnology
CA
2024
Offer Letter between Jade Biosciences, Inc. and Jonathan Quick, dated as of August 29, 2024
Aerovate Therapeutics, Inc.
Biotechnology
MA
2024
Offer Letter between Jade Biosciences, Inc. and Tom Frohlich, dated as of August 20, 2024
Aerovate Therapeutics, Inc.
Biotechnology
2024
Description of Securities
Aerovate Therapeutics, Inc.
Biotechnology
2022
Offer Letter between the Registrant and Ralph Niven, dated April 26, 2020
Aerovate Therapeutics, Inc.
Biotechnology
MA
2021
Offer Letter between the Registrant and Hunter Gillies, dated April 27, 2020
Aerovate Therapeutics, Inc.
Biotechnology
MA
2021
Offer Letter between the Registrant and Benjamin T. Dake, dated November 4, 2019
Aerovate Therapeutics, Inc.
Biotechnology
MA
2021